OSE.PA
Ose Immunotherapeutics SA
Price:  
5.87 
EUR
Volume:  
136,067.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OSE.PA WACC - Weighted Average Cost of Capital

The WACC of Ose Immunotherapeutics SA (OSE.PA) is 9.2%.

The Cost of Equity of Ose Immunotherapeutics SA (OSE.PA) is 10.60%.
The Cost of Debt of Ose Immunotherapeutics SA (OSE.PA) is 5.00%.

Range Selected
Cost of equity 8.00% - 13.20% 10.60%
Tax rate 1.90% - 3.70% 2.80%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.2% - 11.2% 9.2%
WACC

OSE.PA WACC calculation

Category Low High
Long-term bond rate 3.0% 3.5%
Equity market risk premium 5.8% 6.8%
Adjusted beta 0.85 1.35
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.00% 13.20%
Tax rate 1.90% 3.70%
Debt/Equity ratio 0.3 0.3
Cost of debt 5.00% 5.00%
After-tax WACC 7.2% 11.2%
Selected WACC 9.2%

OSE.PA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for OSE.PA:

cost_of_equity (10.60%) = risk_free_rate (3.25%) + equity_risk_premium (6.30%) * adjusted_beta (0.85) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.